Last updated on May 2018

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in participants who are biologic-naive and biologic-experienced.

Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a separate, long-term extension (LTE) study (Gilead Study GS-US-418-3899).

Clinical Study Identifier: NCT02914522

Contact Investigators or Research Sites near you

Start Over

Gilead Clinical Study Information Center

The Queen Elizabeth Hospital
Woodville South, Australia
  Connect »

Gilead Clinical Study Information Center

Flinders Medical Centre
Bedford Park, Australia
9.85miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.